We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

DSM Announces License Agreement with Amgen

News   Jan 15, 2013

 
DSM Announces License Agreement with Amgen
 
 
Advertisement
 

RELATED ARTICLES

New Testing Approach Could Help Scientists Spot Resistance to Cancer Drugs

News

Purdue University engineers have designed a new way to observe pancreatic cancer behavior over time, suggesting a new drug testing approach that could help scientists better catch resistance.

READ MORE

Delayed Wound Healing Due to Gene Mutations

News

A gene mutation underlying various inflammatory skin disorders also delays wound healing but there are ways to normalize the process, scientists suggest.

READ MORE

Heart–Breast Cancer-on-a-Chip Developed To Monitor Cardiac Toxicity Arising From Chemo

News

Researchers have developed an organ-on-a-chip system that more widely examines the responses of breast cancer and heart tissues to breast cancer drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE